Dynorphin selectively augments the M-current in hippocampal CA1 neurons by an opiate receptor mechanism

Journal of Neurophysiology

Volumn 82, Issue 4, 1999, Pages 1768-1775

  Madamba, Samuel G ^a   Schweitzer, Paul ^a   Siggins, George Robert ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYNORPHIN; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HIPPOCAMPUS; INTERNEURON; MOLECULAR CLONING; NERVE CONDUCTION; NEUROTRANSMITTER RELEASE; NONHUMAN; POSTSYNAPTIC INHIBITION; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; RECEPTOR DENSITY;

EID: 0032870122     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.1999.82.4.1768     Document Type: Article

References (67)

1. ARVIDSSON, U., RIEDL, M., CHAKRABARTI, S., LEE, J. H., NAKANO, A. H., DADO, R. J., LOH, G. L., LAW, P.-Y., WESSENDORF, M. W., AND ELDE, R. Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci. 15: 3328-3341, 1995a.
2. ARVIDSSON, U., RIEDL, M., CHAKRABARTI, S., VULCHANOVA, L., LEE, J.-H., NAKANO, A. H., LIN, X., LOH, H. H., LAW, P.-Y., WESSENDORF, M. W., AND ELDE, R. The kappa-opioid receptor is primarily postsynaptic: combined immunohistochemical localization of the receptor and endogenous opioids. Proc. Natl. Acad. Sci. USA 92: 5062-5066, 1995b.
3. CASTILLO, P. E., SALIN, P. A., WEISSKOPF, M. G., AND NICOLL, R. A. Characterizing the site and mode of action of dynorphin at hippocampal mossy fiber synapses in the guinea pig. J. Neurosci. 16: 5942-5950, 1996.
4. CHAVKIN, C., HENRIKSEN, S. J., SIGGINS, G. R., AND BLOOM, F. E. Selective inactivation of opioid receptors in rat hippocampus demonstrates that dynorphin-A and -B may act on mu-receptors in the CA1 region. Brain Res. 331: 366-370, 1985a.
5. CHAVKIN, C., JAMES, I. F., AND GOLDSTEIN, A. Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 215: 413-415, 1982.
6. CHAVKIN, C., SHOEMAKER, W. J., MCGINTY, J. F., BAYON, A., AND BLOOM, F. E. Characterization of pro-dynorphin and pro-enkephalin neuropeptide systems in rat hippocampus. J. Neurosci. 5: 808-816, 1985b.
7. 3 subtype. J. Pharmacol. Exp. Ther. 251: 461-468, 1989.
8. COMMONS, K. G. AND MILNER, T. A. Localization of delta opioid receptor immunoreactivity in interneurons and pyramidal cells in the rat hippocampus. J. Comp. Neurol. 381: 373-387, 1997.
9. DEISZ, R. A., MADAMBA, S., MOORE, S., SIGGINS, G. R., SUTOR, B., AND ZIEGLGÄNSBERGER, W. Regulation of neuronal excitability by opioid peptides: intracellular analysis in several brain regions. In: Regulatory Role of Opioid Peptides, edited by I. Pataki, P. Illes, and C. Farsang, Weinheim, Germany: VCH Press, 1988, p. 147-164.
10. DERRICK, B. E., RODRIGUEZ, S. B., LIEBERMAN, D. N., AND MARTINEZ, J. L., JR. Mu opioid receptors are associated with the induction of hippocampal mossy fiber long-term potentiation. J. Pharmacol. Exp. Ther. 263: 725-733, 1992.
11. DRAKE, C. T., PATTERSON, T. A., SIMMONS, M. L., CHAVKIN, C., AND MILNER, T. A. Kappa opioid receptor-like immunoreactivity in guinea pig brain: ultrastructural localization in presynaptic terminals in hippocampal formation. J. Comp. Neurol. 370: 377-395, 1996.
12. FINKEL, A. S. AND REDMAN, S. J. Optimal voltage clamping with single microelectrodes. In: Voltage and Patch Clamping With Microelectrodes, edited by T. G. Smith, H. Lecar, S. J. Redman, and P. W. Gage. Baltimore, MD: Williams and Wilkins, 1985, p. 95-120.
13. FRANCESCONI, W., BERTON, F., DEMURO, A., MADAMBA, S. G., AND SIGGINS, G. R. Naloxone blocks long-term depression of excitatory transmission in rat CA1 hippocampus in vitro. Arch. Ital. Biol. 135: 37-48, 1997.
14. GALL, C. Seizures induce dramatic and distinctly different changes in enkephalin, dynorphin and CCK immunoreactivities in mouse hippocampal mossy fibers. J. Neurosci. 8: 1852-1862, 1988.
15. GRAMHAM, C. R., MILGRAM, M. W., AND SERBRO, B. Delta opioid receptor activation is required to induce LTP of synaptic transmission in the lateral perforant path in vivo. Brain Res. 567: 42-50, 1991.
16. GROSS, R. A. AND MACDONALD, R. L. Dynorphin A selectively reduces a large transient (N-type) calcium current of mouse dorsal root ganglion neurons in cell culture. Proc. Natl. Acad. Sci USA 84: 5469-5473, 1987.
17. GRUDT, T. J. AND WILLIAMS, J. T. Kappa-opioid receptors also increase potassium conductance. Proc. Natl. Acad. Sci. USA 90: 11429-11432, 1993.
18. HALLIWELL, J. V. AND ADAMS, P. R. Voltage-clamp analysis of muscarinic excitation in hippocampal neurons. Brain Res. 250: 71-92, 1982.
19. HENRY, D. J., GRANDY, D. K., LESTER, H. A., DAVIDSON, N., AND CHAVKIN, C. Kappa-opioid receptors couple to inwardly rectifying potassium channels when coexpressed by Xenopus oocytes. Mol. Pharmacol. 47: 551-557, 1995.
20. HONG, J. S., MCGINTY, J. F., GRIMES, L., KANAMATSU, T., OBIE, J., AND MITCHELL, C. L. Seizure-induced alterations in the metabolism of hippocampal opioid peptides suggest opioid modulation of seizure-related behaviors. NIDA Res. Monogr. 82: 48-66, 1988.
21. + channel. Biochem. Biophys. Res. Commun. 208: 302-308, 1995.
22. B receptor activation. Brain Res. 821: 286-293, 1999.
23. JOHNSTON, D. AND BROWN, T. H. Interpretation of voltage-clamp measurements in hippocampal neurons. J. Physiol. (Lond.) 50: 464-486, 1983.
24. JONES, L. S. Naloxone blocks antiepileptogenic properties of an in vitro electroconvulsive shock model. Brain Res. 564: 336-340, 1991.
25. LUPICA, C. R. AND DUNWIDDIE, T. V. Differential effects of mu- and delta-receptor selective opioid agonists on feedforward and feedback GABAergic inhibition in hippocampal brain slices. Synapse 8: 237-248, 1991.
26. LUPICA, C. R., PROCTOR, W. R., AND DUNWIDDIE, T. V. Dissociation of mu and delta opioid receptor-mediated reductions in evoked and spontaneous synaptic inhibition in the rat hippocampus in vitro. Brain Res. 593: 226-238, 1992.
27. + channel by a G protein-linked mechanism: coexpression in Xenopus oocytes. Mol. Pharmacol. 47: 1035-1040, 1995.
28. MADAMBA, S. G., SCHWEITZER, P., ZIEGLGÄNSBERGER, W., AND SIGGINS, G. R. Acamprosate (calcium acetylhomotaurinate) enhances the N-methyl-D-aspartate component of excitatory neurotransmission in rat hippocampal CA1 neurons in vitro. Alcohol. Clin. Exp. Res. 20: 651-658, 1996.
29. MADISON, D. V., LANCASTER, B., AND NICOLL, R. A. Voltage-clamp analysis of cholinergic action in the hippocampus. J. Neurosci. 7: 733-741, 1987.
30. MADISON, D. V. AND NICOLL, R. A. Enkephalin hyperpolarizes interneurones in the rat hippocampus. J. Physiol. (Lond.) 398: 123-130, 1988.
31. MARTIN, G., NIE, Z., AND SIGGINS, G. R. Mu opioid receptors modulate N-methyl-D-aspartate-receptor-mediated responses in nucleus accumbens neurons. J. Neurosci. 17: 11-22, 1997.
32. MCDANIEL, K. L., MUNDY, W. R., AND TILSON, H. A. Microinjection of dynorphin into the hippocampus impairs spatial learning. Pharmacol. Biochem. Behav. 35: 429-435, 1990.
33. MCGINTY, J. R, HENRIKSEN, S. J., GOLDSTEIN, A., TERENIUS, L., AND BLOOM, F. E. Dynorphin is contained within hippocampal mossy fibers: immunochemical alterations after kainic acid administration and colchicine-induced neurotoxicity. Proc. Natl. Acad Sci. USA 80: 589-593, 1983.
34. MOORE, S. D., MADAMBA, S. G., JOELS, M., AND SIGGINS, G. R. Somatostatin augments the M-current in hippocampal neurons. Science 239: 278-280, 1988a.
35. MOORE, S. D., MADAMBA, S. G., SCHWEITZER, P., AND SIGGINS, G. R. Voltage-dependent effects of opioid peptides on hippocampal CA3 pyramidal neurons in vitro. J. Neurosci. 14: 809-820, 1994.
36. MOORE, S. D., MADAMBA, S. G., ZIEGLGANSBERGER, W., AND SIGGINS, G. R. Enkephalin analogues depress synaptic potentials in rat dentate granule cells recorded intracellularly in vitro. Neurosci. Lett. 91: 71-76, 1988b.
37. NEUMAIER, J. F., MAILHEAU, S., AND CHAVKIN, C. Opioid receptor-mediated responses in the dentate gyrus and CA1 region of the rat hippocampus. J. Pharmacol. Exp. Ther. 244: 564-570, 1988.
38. NICOLL, R. A., ALGER, B. E., AND YAHR, C. E. Enkephalin blocks inhibitory pathways in the vertebrate CNS. Nature 287: 22-25, 1980.
39. NOCK, B., GIORDANO, A. L., CICERO, T. J., AND O'CONNOR, L. H. Affinity of drugs and peptides for U-69,593-sensitive and -insensitive kappa opiate binding sites: the U-69,593-insensitive site appears to be the beta endorphin-specific epsilon receptor. J. Pharmacol. Exp. Ther. 254: 412-419, 1990.
40. NOCK, B., GIORDANO, G., MOORE, B. W., AND CICERO, T. J. Properties of the putative epsilon opioid receptor: identification in rat, guinea pig, cow, pig, and chicken brain. J. Pharmacol. Exp. Ther. 264: 349-359, 1993.
41. 3H]ethylketocyclazocine. Life Sci. 42: 2403-2412, 1988.
42. NORTH, R. A., WILLIAMS, J. T., SURPRENANT, A., AND CHRISTIE, M. J. Mu and delta receptors belong to a family of receptors that are coupled to potassium channels. Proc. Natl. Acad. Sci. USA 84: 5487-5491, 1987.
43. PIGUET, P. AND NORTH, R. A. Opioid actions at mu and delta receptors in the rat dentate gyrus in vitro. J. Pharmacol. Exp. Ther. 266: 1139-1149, 1993.
44. SALIN, P. A., WEISSKOPF, M. G., AND NICOLL, R. A. A comparison of the role of dynorphin in the hippocampal mossy fiber pathway in guinea pig and rat. J. Neurosci. 15: 6939-6945, 1995.
45. SANDIN, J., NYLANDER, I., GEORGIEVA, J., SCHÖTT, P. A., ÖGREN, S. O., AND TERENIUS, L. Hippocampal dynorphin B injections impair spatial learning in rats: a κ-opioid receptor-mediated effect. Neuroscience 85: 375-382, 1998.
46. SCHWEITZER, P., MADAMBA, S., AND SIGGINS, G. R. Somatostatin inhibition of hippocampal CA1 pyramidal neurons: mediation by arachidonic acid and its metabolites. J. Neurosci. 13: 2033-2049, 1993.
47. SIGGINS, G. R. Electrophysiological actions of opioids on central neurons. In: New Leads in Opioid Research, edited by J. M. van Ree, A. H. Mulder, V. M. Wiegant, and T. van Wimersma Greidanus. Amsterdam: Excerpta Medica, 1990, p. 293-294.
48. SIGGINS, G. R. AND GRUOL, D. L. Mechanisms of transmitter action in the vertebrate central nervous system. In: Handbook of Physiology. The Nervous System. Intrinsic Regulatory Systems of the Brain. Bethesda, MD: Am. Physiol. Soc., 1986, sect. 1, vol. IV, p. 1-114.
49. SIGGINS, G. R., HENRIKSEN, S. J., CHAVKIN, C., AND GRUOL, D. Opioid peptides and epileptogenesis in the limbic system: cellular mechanisms. Adv. Neurol. 44: 501-512, 1986.
50. SIGGINS, G. R. AND ZIEGLGÄNSBERGER, W. Morphine and opioid peptides reduced inhibitory synaptic potentials in hippocampal pyramidal cells in vitro without alteration of membrane potential. Proc. Natl. Acad. Sci. USA 78: 5235-5239, 1981.
51. SIMMONS, M. L. AND CHAVKIN, C. κ-Opioid receptor activation of a dendrotoxin-sensitive potassium channel mediates presynaptic inhibition of mossy fiber neurotransmitter release. Mol. Pharmacol. 50: 80-85, 1996.
52. 5-enkephalin and dynorphin A (1-17) on neocortical neurons in vitro. Neuropeptides 5: 241-244, 1984.
53. TEMPEL, A. AND ZUKIN, R. S. Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography. Proc. Natl. Acad, Sci. USA 84: 4308-4312, 1987.
54. TERMAN, G. W., WAGNER, J. J., AND CHAVKIN, C. Kappa opioids inhibit induction of long-term potentiation in the dentate gyrus of the guinea pig hippocampus. J. Neurosci. 14: 4740-4747, 1994.
55. TORTELLA, F. C. AND HOLADAY, J. W. Dynorphin A (1-13) in vivo opioid antagonist actions and non-opioid anticonvulsant effects in the rat flurothyl test. NIDA Res. Monogr. 75: 539-542, 1986.
56. UNNERSTALL, J. R., MOLLIVER, M. E., KUHAR, M. J., AND PALACIOS, J. M. Ontogeny of opiate binding sites in the hippocampus, olfactory bulb and other regions of the rat forebrain by autoradiographic methods. Brain Res. 283: 157-169, 1983.
57. WAGNER, J. J., CAUDLE, R. M., AND CHAVKIN, C. κ-Opioids decrease excitatory transmission in the dentate gyrus of the guinea pig hippocampus. J. Neurosci. 12: 132-141, 1992.
58. WAGNER, J. J., TERMAN, G. W., AND CHAVKIN, C. Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus. Nature 363: 451-454, 1993.
59. WEISSKOPF, M. G., ZALUTSKY, R. A., AND NICOLL, R. A. The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fiber synapses and modulates long-term potentiation. Nature 362: 423-427, 1993
60. WILLIAMS, J. T. AND NORTH, R. A. Opiate-receptor interactions on single locus coeruleus neurones. Mol. Pharmacol. 26: 489-497, 1984.
61. WILLIAMS, J. T., NORTH, R. A., AND TOKIMASA, T. Inward rectification of resting and opiate-activated potassium currents in rat locus coeruleus neurons. J. Neurosci. 8: 4299-4306, 1988.
62. WOLLEMANN, M., BENYHE, S., AND SIMON, J. The kappa-opioid receptor: evidence for the different subtypes. Life Sci. 52: 599-611, 1993.
63. XIE, C. W. AND LEWIS, D. V. Endogenous opioids regulate long-term potentiation of synaptic inhibition in the dentate gyrus of rat hippocampus. J. Neurosci. 15: 3788-3795, 1995.
64. YUAN, X., MADAMBA, S. G., AND SIGGINS, G. R. Opioid peptides reduce synaptic transmission in the nucleus accumbens. Neurosci. Lett. 134: 223-228, 1992.
65. ZHANG, L., YU, Y., MACKIN, S., WEIGHT, F. F., UHL, G. R., AND WANG, J. B. Differential μ opiate receptor phosphorylation and desensitization induced by agonists and phorbol esters. J. Biol. Chem. 271: 11449-11454, 1996.
66. ZIEGLGANSBERGER, W., FRENCH, E. D., SIGGINS, G. R., AND BLOOM, F. E. Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons. Science 205: 415-417, 1979.
67. 2 opioid receptors. Proc. Natl. Acad. Sci. USA 85: 4061-4065, 1988.